Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Stephen Walsh

27PUBLICATIONS
176CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsEpidemiological modellingVenereologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

Sort by Publication Date:
|Apr 10, 2026
Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300).

Stephen Walsh, William O Hahn, Wilton B Williams

|Nov 26, 2025
Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challenge.

Urjeet S Khanwalkar, Jennifer Fields, Joshua A Wiener

|Jul 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.

K Rachael Parks, Zoe Moodie, Mary A Allen

|Apr 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).

Sharon A Riddler, Zoe Moodie, Jesse Clark

|Apr 11, 2025
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost.

Leigh H Fisher, Erica Lazarus, Chenchen Yu

|Jun 24, 2024
Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial.

Stephen R Walsh, Cynthia L Gay, Shelly T Karuna

Pageof 5

Frequent Collaborators

5 joint publications

David Montefiori

4 joint publications

Yehuda Z Cohen

4 joint publications

Zoe Moodie

4 joint publications

Georgia D Tomaras

4 joint publications

Kelly Seaton

3 joint publications

Janneke Van't Hooft

3 joint publications

Andreas M Schmitt

3 joint publications

Guiseppe Pantaleo

3 joint publications

Mary Allen

3 joint publications

Maurine D Miner

Frequent Collaborators

5 joint publications

David Montefiori

4 joint publications

Yehuda Z Cohen

4 joint publications

Zoe Moodie

4 joint publications

Georgia D Tomaras

Top Related Videos

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on : Sep 14, 2014

14.8K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on : Dec 03, 2019

10.5K
See more related videos

Top Related Videos

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on : Sep 14, 2014

14.8K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on : Dec 03, 2019

10.5K
See more related videos